One of the observed anti-inflammatory effects of semaglutide is the effect on the reduction of CRP, which can be used as a parameter of the disease course and the psoriasis prognosis, but additional research is necessary to fully clarify this mechanism [14,15,16,17]. Here, CRP is linked to psoriasis.